This Solicitation opportunity from Hawaii was posted on May 11, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

FENTANYL DETECTION, EARLY INTERVENTION - 12 PANEL DRUG TEST KIT

Closed

B26002727State & Local

Submission Closed06/04/2026, 02:30:00 AM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 424210

New

DIBBS

Supply of Cold Weather Gloves (Mechanix Wear)

POSTED

DEADLINE

Supply of Cetirizine Hydrochloride Tablets

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-26-T-4993

Solicitation SPE2DP-26-T-4993, issued by the DLA Troop Support Medical Supply Chain Pharm FSA, seeks quotes for the procurement of Iohexol Injection, USP. The requirement is for two boxes of radiological contrast media, specifically 300mg/ml in 150ml PlusPack polymer bottles, with each box containing ten units. The product must be stored at a controlled room temperature of 20 to 25 degrees Celsius, protected from strong daylight and direct sunlight, and must not be frozen. The item is subject to a non-extendable shelf life of 36 months. Delivery is required within five days after receipt of order, with a required delivery date of September 14, 2026, shipped FOB Destination to the USS Harrisburg LPD-30 Bliss in Mississippi. Packaging must be commercial and compliant with Medical Marking Standard No. 1, which supersedes MIL-STD-129. If the material is deemed hazardous per FED-STD-313, it must follow TQ requirement IP025 and include Safety Data Sheets consistent with 29 C.F.R. 1910.1200. All quotes must be submitted via the DLA Internet Bid Board System by September 16, 2026, and the award may be processed through an automated system.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

DANTROLENE SODIUM FOR

Solicitation # SPE2DP-26-T-4995

Solicitation SPE2DP-26-T-4995 is a total small business set-aside request for quotations issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the acquisition of Dantrolene Sodium for Injection, USP. The requirement consists of two line items, each for a quantity of 6 vials (20 ml per vial), with delivery required within 5 days of award. Delivery is FOB Destination, with shipments directed to the USS Harrisburg LPD-30 Bliss in Gulfport, Mississippi, and the USS Somerset LPD 25. The product must be stored at 20 to 25 degrees Celsius and protected from light, with a non-extendable shelf life of 24 months. The contractor must adhere to strict packaging and marking standards, specifically Medical Marking Standard No. 1, which supersedes MIL-STD-129. Packaging must be commercial per ASTM D3951 unless the material is deemed hazardous under FED-STD-313, in which case TQ requirement IP025 applies. Palletization must comply with RP001. The solicitation incorporates the DLA Master Solicitation for Automated Simplified Acquisitions and requires the use of the Wide Area WorkFlow system for invoicing. Compliance with the Buy American Act, the Berry Amendment, and DFARS cybersecurity standards for safeguarding covered defense information is mandatory.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

OTIC CLEANSING SOLUTIO

Solicitation # SPE2DP-26-T-4996

This contract is for the procurement of four units of veterinary otic cleansing solution, identified by NSN 6509-01-658-2828. The product is a pH-balanced, hypoallergenic acidifying ear cleaner and drying agent for dogs and cats, consisting of 2% malacetic and 2% boric acid in 8 oz containers. The solution must be stored at controlled room temperatures between 20-25 C and has a non-extendable shelf life of 24 months. The agreement specifies delivery to the USA Med Mat Ctr EUR in Kaiserslautern, Germany, with a delivery window of 88 days. All items must be FDA regulated and adhere to Medical Marking Standard No. 1 and MIL-STD-129 for packaging and marking. The contract requires commercial packaging in sealed unit containers to prevent damage during transit, with a strict quantity variance of plus or minus 0%.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

REHYDRATION SALTS FOR

Solicitation # SPE2DP-26-T-4988

Solicitation SPE2DP-26-T-4988 is a request for quotations issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of lemon-flavored electrolyte oral rehydration powder. The requirement is for three packages, with each package containing 100 packets of 21 grams each. Each packet is formulated to provide 665 mg of sodium, 390 mg of potassium, 80 mg of citrate, 83 mg of magnesium, and 3 mg of zinc when dissolved in 16.9 fluid ounces of solution. The specified product is Drip Drop Hydration Inc. part number 61406 under NSN 6505-01-646-2692, and it must have a non-extendable shelf life of 24 months. Delivery is required within 20 days of award, with a required delivery date of September 9, 2026. The shipment is FOB Destination to the USS Tucson (SSN 770) at FPO AP 96679. Inspection and acceptance will also occur at the destination. Packaging must be commercial and compliant with DLA Packaging Requirements for Procurement (RP001) and ASTM D3951, unless the material is deemed hazardous per FED-STD-313, in which case TQ requirement IP025 applies. All materials must be marked according to Medical Marking Standard No. 1, which supersedes MIL-STD-129. The award process may be automated, and the contract incorporates various federal regulations, including the Buy American Act, Berry Amendment, and DFARS cybersecurity standards for safeguarding covered defense information.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

SUNSCREEN PREPARATION

Solicitation # SPE2DP-26-T-4999

Solicitation SPE2DP-26-T-4999 is a request for quotes from the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of sunscreen preparation, identified by NSN 6505-01-657-9247. The required product is an over-the-counter topical sunscreen with SPF 50, containing 4.5 percent titanium dioxide and 4 percent zinc oxide. It must be hypoallergenic, oil-free, PABA-free, biodegradable, and water-resistant for 80 minutes. The unit of issue is a package of 24 three-ounce tubes. The product has a total shelf life of 24 months, with a minimum of 21 months remaining upon receipt by the government. Storage requirements specify a cool, dry place between 15 and 30 degrees Celsius. The contract requires delivery within 20 days of award, with FOB, inspection, and acceptance all occurring at the destination. Packaging must be commercial and sealed to prevent damage, adhering to ASTM D3951 for non-hazardous materials or TQ requirement IP025 for hazardous materials. Marking must comply with Medical Marking Standard No. 1, which supersedes MIL-STD-129 for medical items. The procurement incorporates various FAR and DFARS clauses, including the Buy American Act, the Berry Amendment, and NIST SP 800-171 cybersecurity requirements. Payment and receiving reports must be processed electronically through the Wide Area WorkFlow system.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

REHYDRATION SALTS FOR

Solicitation # SPE2DP-26-T-4989

Solicitation SPE2DP-26-T-4989 is a request for quotations issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of berry flavored electrolyte oral rehydration powder, identified by NSN 6505016462701. The product is an FDA-regulated over-the-counter oral solution powder. Each 21 gram packet must provide 665 mg of sodium, 390 mg of potassium, 80 mg of citrate, 83 mg of magnesium, and 3 mg of zinc when prepared in a 16.9 fl oz solution. The requirement consists of three line items totaling four packages, with each package containing 100 packets. The product must have a total shelf life of 36 months, with at least 31 months remaining upon receipt by the government. Delivery is required within 20 days of order, with an original required delivery date of September 9, 2026, shipped FOB Destination to the USS TUCSON SSN 770. Packaging must comply with DLA packaging requirements and ASTM D3951 for non-hazardous materials, while marking must adhere to Medical Marking Standard No. 1. All quotes must be submitted via the DIBBS system. The procurement incorporates various FAR and DFARS clauses, including requirements for the Buy American Act, Berry Amendment, and NIST SP 800-171 cybersecurity assessments. Inspection and acceptance will occur at the destination.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Pharmaceutical Medication Supplier

Badger Prairie Health Care Center

POSTED

DEADLINE

Pharmaceutical & Vaccine Supply

Omas Strategic Buying Center - HHS Mission

POSTED

DEADLINE

SUNSCREEN PREPARATION

Solicitation # SPE2DP-26-T-4964

This contract is for the procurement of SPF 50 sunscreen preparation for the Department of Defense, specifically for delivery to the USS Paul Hamilton. The product must be an over-the-counter topical preparation containing 4.5 percent titanium dioxide and 4 percent zinc oxide. It is required to be hypoallergenic, oil-free, PABA-free, biodegradable, and water-resistant for 80 minutes. The order consists of 10 packages, with each package containing 24 three-ounce tubes. The sunscreen must have a total shelf life of 24 months, with at least 21 months remaining upon receipt. Storage requirements specify a cool, dry place between 15 and 30 degrees Celsius. Packaging must adhere to commercial standards and Medical Marking Standard No. 1, with specific shipping instructions for vessel delivery. The delivery timeline is set for 20 days after the order, with a required delivery date of September 11, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

SODIUM HYPOCHLORITE SO

Solicitation # SPE2DP-26-T-4965

This contract is for the procurement of one 16 oz bottle of dental sodium hypochlorite solution, identified by NSN 6505016726659. The item is subject to a non-extendable 12-month shelf life and must be stored in a cool, dry, and well-ventilated area. Delivery is required within 20 days to the USS Portland LPD 27 via DLA Distribution San Diego. The supplier must comply with strict hazardous material guidelines, including the submission of Safety Data Sheets and labels consistent with OSHA and 29 C.F.R. 1910.1200 standards. Packaging and marking must adhere to Medical Marking Standard No. 1 and DLA packaging requirements, with specific instructions for hazardous materials under TQ requirement IP025 or commercial packaging via ASTM D3951.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

3 days ago

DEADLINE

in 3 days

AI Contract Overview

The Hawaii Paroling Authority is seeking competitive sealed bids from qualified vendors to establish a statewide price list contract for integrated urine-based 12-panel drug testing kits with fentanyl detection capabilities. These kits are intended to support various supervision and treatment efforts, including clinical monitoring, treatment compliance, abstinence verification, early intervention, and relapse detection for individuals under HPA supervision. The drug testing kits must detect a range of controlled substances — THC, Buprenorphine, Benzodiazepines, Methadone, Amphetamines, Oxycodone, Opiates, MDMA/Ecstasy, Cocaine, Methamphetamine, Alcohol (EtG), and Fentanyl — with high analytical sensitivity to identify low concentrations, meeting clinical monitoring standards. The estimated annual consumption is approximately 6,000 kits, which will be delivered on an as-needed basis to HPA offices across Oahu, Hawaiʻi Island, Maui, and Kauaʻi. The contract is set to begin on July 1, 2026, running through June 30, 2027, with options to extend for three additional one-year periods, contingent on contractor performance, operational need, and funding availability. All submissions and correspondence related to this solicitation must be conducted electronically through the Hawaii electronic procurement system HIePRO, with a response deadline of June 4, 2026. Primary contact for this solicitation is Marc Yamamoto from the Department of Corrections and Rehabilitation, Hawaii.

General Info

Hawaii seeks vendors for statewide urine drug test kits contract, starting July 2026, with extensions.

Agency

Hawaii → Department of Corrections and RehabilitationView Agency

Contract Value

$299

NAICS

424210 - Drugs and Druggists' Sundries Merchant WholesalersView NAICS

Place of Performance

HI, USA

Set-Aside

NONE

Awardee

Biotech ScreeningView Profile

Award Issued Date

06/09/2026, 12:00:00 AM UTC

Documents

(3)

HPA Competitive Seal Bid IFB No 26002727 for Fentanyl Detection Drug Test Kits

PDF•ifb

HPA IFB 26002727 Fentanyl Detection 12-Panel Drug Kits

PDF•ifb

AG-008 103D General Conditions (1.10.23)

PDF•general-conditions

AI Contract Breakdown

Uniform Contract Format

Timeline

PhaseClosed

PostedMay 11

Solicitation

Response DeadlineJun 4

Deadline has passed

Submission Closed

06/04/2026, 02:30:00 AM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyHawaii → Department of Corrections and Rehabilitation

Contacts1 person available

OfficeHI, USA

Organization / Agency

Hawaii → Department of Corrections and Rehabilitation

View Agency Profile

Office AddressHI, USA

Contacts

Earl Everett

contact@example.gov

+1 (555) 000-0000

Full Description

The Hawaii Paroling Authority (HPA) is requesting competitive sealed bids from qualified vendors to establish a Statewide price list contract for the purchase and delivery of integrated urine-based 12-panel drug testing kits with fentanyl detection capabilities. The testing kits will support HPA’s Statewide supervision, clinical monitoring, treatment compliance, abstinence verification, early intervention, and relapse detection efforts for supervised individuals under HPA jurisdiction. Proposed products shall meet clinical monitoring standards and demonstrate high analytical sensitivity for the detection of low concentrations of controlled substances, including fentanyl. The solicitation requires integrated 12-panel drug testing kits capable of detecting the following analytes: THC, Buprenorphine, Benzodiazepines, Methadone, Amphetamines, Oxycodone, Opiates, MDMA/Ecstasy, Cocaine, Methamphetamine, Alcohol (EtG), and Fentanyl. Estimated annual usage is approximately 6,000 kits Statewide. Deliveries will be ordered on an as-needed basis and distributed to HPA offices located on Oahu, Hawaiʻi Island, Maui, and Kauaʻi. The resulting contract term shall be from July 1, 2026 through June 30, 2027, with the option to extend for up to three (3) additional twelve (12)-month periods, subject to satisfactory contractor performance, continued operational need, and availability of funds. All proposals, questions, and solicitation communications shall be submitted electronically through HIePRO in accordance with the solicitation requirements and deadlines.